Study of immune causes of acute respiratory distress
Part of Lungs & breathing clinical trials.
This trial looks at how the immune system might cause severe breathing problems (ARDS). It may help doctors understand what happens in the lungs during this condition and find better ways to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a severe lung infection, major injury, shock, or other condition that can lead to ARDS.
- Your breathing symptoms started less than 7 days ago.
- You have fluid in both lungs that is not caused by a heart problem or too much IV fluids.
- Your oxygen level in blood is low (PaO2/FiO2 of 300 or less) while on breathing support (PEEP of at least 5 cmH2O).
- You have not been on a breathing tube for longer than 48 hours.
- You do not have a condition that weakens your immune system, such as active cancer, transplant history, or certain blood problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if a lung test called the recruitment-to-inflation ratio gives the same result when done more than once. The test helps doctors understand how much of the lung can be opened up with more pressure from the breathing machine. This may help improve care for patients with severe lung injury.
This trial observes the symptoms, treatments, and recovery of patients with acute respiratory distress syndrome (ARDS), a serious lung condition. It aims to learn more about how different types of breathing support affect outcomes.
This study looks at blood and sputum samples from people with ARDS (a severe lung condition) to find what affects their recovery. It might help doctors better understand how to treat ARDS in the future.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This study looks at how the immune system and ECMO (a machine that helps oxygenate blood) can improve outcomes for people with moderate to severe ARDS. If you join, researchers will monitor your condition and treatment to find better ways to manage this serious lung problem.
This trial studies two ways to measure how much of your lungs can open up again (recruitability) to help doctors set the best breathing machine pressure. It may help improve oxygen levels in patients with severe lung injury.
Hear when a new Acute Respiratory Distress Syndrome (ARDS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.